INO logo

Inovio Pharmaceuticals (INO) Current Assets

Annual Current Assets

$153.11 M
-$162.13 M-51.43%

31 December 2023

INO Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$91.28 M
-$26.28 M-22.35%

30 September 2024

INO Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

INO Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-51.4%-47.8%
3 y3 years-67.5%-81.3%
5 y5 years+74.4%-7.6%

INO Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-67.5%at low-81.3%at low
5 y5 years-67.5%+74.4%-84.5%at low
alltimeall time-67.5%+5575.3%-84.5%+8254.8%

Inovio Pharmaceuticals Current Assets History

DateAnnualQuarterly
Sept 2024
-
$91.28 M(-22.4%)
June 2024
-
$117.56 M(+5.3%)
Mar 2024
-
$111.68 M(-27.1%)
Dec 2023
$17.84 M(-46.4%)
$153.11 M(-12.4%)
Sept 2023
-
$174.77 M(-14.0%)
June 2023
-
$203.28 M(-13.1%)
Mar 2023
-
$233.90 M(-25.8%)
Dec 2022
$33.29 M(-29.9%)
$315.24 M(-10.0%)
Sept 2022
-
$350.21 M(-15.9%)
June 2022
-
$416.19 M(+4.1%)
Mar 2022
-
$399.91 M(-10.8%)
Dec 2021
$47.50 M(-30.8%)
$448.44 M(-8.0%)
Sept 2021
-
$487.40 M(-10.1%)
June 2021
-
$542.42 M(-7.8%)
Mar 2021
-
$588.43 M(+24.9%)
Dec 2020
$68.60 M(+37.9%)
$471.17 M(+25.0%)
Sept 2020
-
$377.06 M(-1.3%)
June 2020
-
$382.06 M(+38.7%)
Mar 2020
-
$275.54 M(+192.5%)
Dec 2019
$49.75 M(+14.9%)
$94.20 M(-4.7%)
Sept 2019
-
$98.81 M(-10.6%)
June 2019
-
$110.51 M(-18.1%)
Mar 2019
-
$134.90 M(+53.6%)
Dec 2018
$43.30 M(-11.4%)
$87.81 M(-6.2%)
Sept 2018
-
$93.60 M(-8.1%)
June 2018
-
$101.84 M(-17.8%)
Mar 2018
-
$123.84 M(-10.5%)
Dec 2017
$48.88 M(-0.5%)
$138.36 M(-10.5%)
Sept 2017
-
$154.59 M(+44.6%)
June 2017
-
$106.88 M(+0.1%)
Mar 2017
-
$106.78 M(-14.3%)
Dec 2016
$49.11 M(+17.0%)
$124.60 M(-11.1%)
Sept 2016
-
$140.23 M(-5.2%)
June 2016
-
$147.97 M(-7.9%)
Mar 2016
-
$160.60 M(-6.5%)
Dec 2015
$41.99 M(+27.9%)
$171.85 M(-6.6%)
Sept 2015
-
$184.07 M(+13.5%)
June 2015
-
$162.14 M(+85.7%)
Mar 2015
-
$87.33 M(-11.7%)
Dec 2014
$32.84 M(+10.9%)
$98.95 M(-5.4%)
Sept 2014
-
$104.64 M(-7.4%)
June 2014
-
$112.94 M(-7.2%)
Mar 2014
-
$121.68 M(+107.4%)
Dec 2013
$29.60 M(+1.5%)
$58.68 M(+1.4%)
Sept 2013
-
$57.85 M(+126.6%)
June 2013
-
$25.54 M(-15.8%)
Mar 2013
-
$30.32 M(+89.9%)
Dec 2012
$29.17 M(-0.1%)
$15.97 M(-5.7%)
Sept 2012
-
$16.93 M(-20.6%)
June 2012
-
$21.32 M(-20.9%)
Mar 2012
-
$26.94 M(-15.6%)
Dec 2011
$29.20 M
$31.91 M(-2.5%)
DateAnnualQuarterly
Sept 2011
-
$32.73 M(-15.2%)
June 2011
-
$38.61 M(-9.1%)
Mar 2011
-
$42.48 M(+85.7%)
Dec 2010
$33.19 M(-8.0%)
$22.88 M(-5.7%)
Sept 2010
-
$24.27 M(-11.1%)
June 2010
-
$27.32 M(-36.7%)
Mar 2010
-
$43.12 M(-3.2%)
Dec 2009
$36.06 M(+52.0%)
$44.57 M(-8.0%)
Sept 2009
-
$48.43 M(+99.6%)
June 2009
-
$24.26 M(+95.2%)
Mar 2009
-
$12.42 M(-18.6%)
Dec 2008
$23.72 M(+120.3%)
$15.26 M(+93.2%)
Sept 2008
-
$7.90 M(-14.4%)
June 2008
-
$9.23 M(-25.4%)
Mar 2008
-
$12.37 M(-57.4%)
Dec 2007
$10.77 M(-6.2%)
$29.00 M(-2.1%)
Sept 2007
-
$29.62 M(-10.2%)
June 2007
-
$32.99 M(+61.5%)
Mar 2007
-
$20.43 M(-16.5%)
Dec 2006
$11.48 M(+7.7%)
$24.47 M(+168.9%)
Sept 2006
-
$9.10 M(-25.0%)
June 2006
-
$12.14 M(-20.6%)
Mar 2006
-
$15.29 M(-16.5%)
Dec 2005
$10.66 M(+324.1%)
$18.32 M(+196.1%)
Sept 2005
-
$6.19 M(-40.1%)
June 2005
-
$10.33 M(-20.5%)
Mar 2005
-
$12.99 M(-29.6%)
Dec 2004
$2.51 M(+1.4%)
$18.44 M(-8.7%)
Sept 2004
-
$20.20 M(-9.2%)
June 2004
-
$22.24 M(+68.3%)
Mar 2004
-
$13.22 M(-3.9%)
Dec 2003
$2.48 M(-9.0%)
$13.75 M(+84.9%)
Sept 2003
-
$7.44 M(+580.8%)
June 2003
-
$1.09 M(-53.6%)
Mar 2003
-
$2.36 M(-12.6%)
Dec 2002
$2.72 M(-10.1%)
$2.70 M(-29.6%)
Sept 2002
-
$3.83 M(-25.1%)
June 2002
-
$5.11 M(+122.9%)
Mar 2002
-
$2.29 M(-40.7%)
Dec 2001
$3.03 M(-6.5%)
-
Sept 2001
-
$3.87 M(-33.0%)
June 2001
-
$5.77 M(-30.0%)
Mar 2001
-
$8.25 M(+41.7%)
Mar 2001
$3.24 M(+35.0%)
-
Dec 2000
-
$5.82 M(-27.7%)
Sept 2000
-
$8.05 M(-21.8%)
June 2000
-
$10.29 M(-11.4%)
Mar 2000
$2.40 M(+8.6%)
$11.61 M(-10.0%)
Dec 1999
-
$12.90 M(-10.4%)
Sept 1999
-
$14.40 M(-9.4%)
June 1999
-
$15.90 M(+109.2%)
Mar 1999
$2.21 M
$7.60 M(-23.2%)
Dec 1998
-
$9.90 M

FAQ

  • What is Inovio Pharmaceuticals annual total current assets?
  • What is the all time high annual current assets for Inovio Pharmaceuticals?
  • What is Inovio Pharmaceuticals annual current assets year-on-year change?
  • What is Inovio Pharmaceuticals quarterly total current assets?
  • What is the all time high quarterly current assets for Inovio Pharmaceuticals?
  • What is Inovio Pharmaceuticals quarterly current assets year-on-year change?

What is Inovio Pharmaceuticals annual total current assets?

The current annual current assets of INO is $153.11 M

What is the all time high annual current assets for Inovio Pharmaceuticals?

Inovio Pharmaceuticals all-time high annual total current assets is $471.17 M

What is Inovio Pharmaceuticals annual current assets year-on-year change?

Over the past year, INO annual total current assets has changed by -$162.13 M (-51.43%)

What is Inovio Pharmaceuticals quarterly total current assets?

The current quarterly current assets of INO is $91.28 M

What is the all time high quarterly current assets for Inovio Pharmaceuticals?

Inovio Pharmaceuticals all-time high quarterly total current assets is $588.43 M

What is Inovio Pharmaceuticals quarterly current assets year-on-year change?

Over the past year, INO quarterly total current assets has changed by -$83.48 M (-47.77%)